Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis
- 1 July 2017
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 128, 1-6
Abstract
No abstract availableKeywords
Funding Information
- Tenovus Scotland
- Sociedad española de neumología
- Fundació Catalana de Pneumologia
- Societat Catalana de Pneumologia
- EMBARC (A European Respiratory Society Clinical Research Collaboration
This publication has 31 references indexed in Scilit:
- Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistanceRespiratory Medicine, 2015
- Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis as a diagnostic tool: A systematic reviewJournal of Cystic Fibrosis, 2014
- National BTS bronchiectasis audit 2012: is the quality standard being adhered to in adult secondary care?Thorax, 2013
- Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group reportJournal of Cystic Fibrosis, 2011
- British Thoracic Society guideline for non-CFbronchiectasisThorax, 2010
- Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methodsJournal of Cystic Fibrosis, 2009
- Microbiologic follow-up study in adult bronchiectasisRespiratory Medicine, 2007
- The effect ofPseudomonas aeruginosaon pulmonary function in patients with bronchiectasisEuropean Respiratory Journal, 2006
- Cystic Fibrosis Adult CareChest, 2004